News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Diala Atassi was appointed as Chief Global and National Programs Officer at The University of Chicago Medicine
Photo from Diala Atassi/LinkedIn
Jan 5, 2024, 11:51

Diala Atassi was appointed as Chief Global and National Programs Officer at The University of Chicago Medicine

Diala Atassi, Chief Global and National Programs Officer at UChicago Medicine, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Chief Global and National Programs Officer at The University of Chicago Medicine!”

Source: Diala Atassi/LinkedIn

cancer career Diala Atassi new position OncoDaily Oncology The University of Chicago Medicine UChicago Medicine
Special Coverage
Blog
Mar 29, 2025, 18:49
Sumanta K. Pal: Tremendous Names on the Fellows of ASCO List
Blog
Mar 29, 2025, 18:37
We had the pleasure of welcoming student to our ‘Careers in Cancer Research’ evening - ICR
Blog
Mar 29, 2025, 18:25
$22.13 billion economic impact on the city of Nashville and across Tennessee - Vanderbilt University
Blog
Mar 29, 2025, 18:18
Gertjan Rasschaert: EORTC GI Cancer Group Held Two-Day Meeting on Research and Neoadjuvant Treatment at KU Leuven
Blog
Mar 29, 2025, 18:13
JJ Singleton: Get ready for something amazing on the Cracking Cancer Podcast
Blog
Mar 29, 2025, 18:03
Marina Puchinskaya: It was an incredible lecture from ELCC 25
Blog
Mar 29, 2025, 18:02
Wade Swenson: Collaboration is a necessity in today’s healthcare landscape
Blog
Mar 29, 2025, 17:57
Maryam Lustberg on optimizing post-cancer life management - GBECAM
Blog
Mar 29, 2025, 17:44
Wafik El-Deiry: Excellent presentation by Herbert Levine at Life Meets Mathematics Workshop
Blog
Mar 29, 2025, 17:40
Evandro de Azambuja: Another way of serving our members and patients
Blog
Mar 29, 2025, 17:30
Eric Singhi: My thoughts on the COCOON trial from ELCC25
Blog
Mar 29, 2025, 17:16
Valerie Yang: So wonderful to have had over 200 registrants to come join us in discussing sarcoma management